Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Low-dose Aspirin for Stomach Cancer Prevention After Endoscopic Resection of Gastric Neoplasm (EASTERN): a Randomized Controlled Trial

NCT04214990 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT04214990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04214990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Low-dose Aspirin for Stomach Cancer Prevention After Endoscopic Resection of Gastric Neoplasm (EASTERN): a Randomized Controlled Trial
Lead sponsor
National Cancer Center, Korea
Phase
Phase 3
Overall status
Recruiting
Start date
February 15, 2020
Completion date
March 31, 2032
Enrollment
1,700 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, gastric cancer